Use of 2′-SpirocyclicEthers in HCV NucleosideDesign.

MLA

Du, Jinfa, et al. “Use of 2′-SpirocyclicEthers in HCV NucleosideDesign.” Journal of Medicinal Chemistry, vol. 57, no. 5, Mar. 2014, pp. 1826–35. EBSCOhost, https://doi.org/10.1021/jm401224y.

APA

Du, J., Chun, B.-K., Mosley, R. T., Bansal, S., Bao, H., Espiritu, C., Lam, A. M., Murakami, E., Niu, C., Micolochick Steuer, H. M., Furman, P. A., & Sofia, M. J. (2014). Use of 2′-SpirocyclicEthers in HCV NucleosideDesign. Journal of Medicinal Chemistry, 57(5), 1826–1835. https://doi.org/10.1021/jm401224y

Chicago

Du, Jinfa, Byoung-Kwon Chun, Ralph T. Mosley, Shalini Bansal, Haiying Bao, Christine Espiritu, Angela M. Lam, et al. 2014. “Use of 2′-SpirocyclicEthers in HCV NucleosideDesign.” Journal of Medicinal Chemistry 57 (5): 1826–35. doi:10.1021/jm401224y.